Qiuning Sun

Dr. Qiuning Sun


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2022 in Photodiagnosis and Photodynamic Therapy
Verified
Journal Article
Closed access
ALAnqi Li
Anqi Li
RFRouyu Fang
Rouyu Fang
XMXuming Mao
Xuming Mao
QSQiuning Sun
Qiuning Sun

14 July 2022 in Dermatologic Surgery
Verified
Journal Article
Closed access
ALAnqi Li
Anqi Li
ALAnyin Long
Anyin Long
RFRouyu Fang
Rouyu Fang
XMXuming Mao
Xuming Mao
QSQiuning Sun
Qiuning Sun
BACKGROUND: Injectable poly-l-lactic acid (PLLA) is a new type of biodegradable dermal filler that has been utilized for soft tissue filling. However, there is no convenient and reliable method to assess the long-term safety of PLLA filler. OBJECTIVE: To assess the long-term safety of PLLA injection into nasolabial folds by high-frequency ultrasound and to select the ultrasonic probes with the most appropriate frequency. MATERIALS AND METHODS: After a 30-month PLLA injection into the deep dermis of the nasolabial fold, subjects were examined by high-frequency ultrasound with the 20 MHz and 50 MHz probes. RESULTS: Twenty subjects with nasolabial fold contour deficiency were enrolled in this study. After a 30-month PLLA injection in nasolabial folds, PLLA degraded entirely in 16 subjects (16/20, 80%), and abnormal echo in the skin was observed in 4 subjects (4/20, 20%) caused by undegraded PLLA microparticles, PLLA microparticles deposition, fibrous nodules, and granuloma. The 20-MHz probe is more appropriate than the 50-MHz probe for evaluating the adverse effects of PLLA injection. CONCLUSION: High-frequency ultrasound is a rapid, reliable, and noninvasive method to monitor the degradation condition of PLLA and the formation of papules and nodules associated with PLLA injection.

1 May 2013 in European Journal Of Dermatology
Verified
Journal Article
Closed access
KWKuo Wan
Kuo Wan
QJQuan Jing
Quan Jing
QSQiuning Sun
Qiuning Sun
HWHongwei Wang
Hongwei Wang
JZJi-Zhi Zhao
Ji-Zhi Zhao
LKLing-Jia Kong
Ling-Jia Kong
The aim was to develop a technique for peripheral nerve block anesthesia (PNB) for the skin of the entire face and neck, considering the nerves anesthetized, injection sites, use of an injection method assisted by computer-controlled local anesthetic delivery (CCLAD), and to evaluate the analgesic effects of the PNB technique. 50 patients who suffered from large nevus of Ota lesions or port-wine stains on their facial and neck skin and who required laser treatment were included. This study was designed as a non-randomized self-control trial. All the patients received the laser treatment under topical anesthesia in the first phase and three to six months later, they received the same treatment under the PNB using CCLAD. The differences in scores from the visual analogue scale of pain for the two phases were analyzed by the t-test. P values <0.05 were considered to be statistically significant. The peripheral nerve block technique was simple to execute and easy to learn, the anesthetic injection site was generally located at a subcutaneous depth of 0.5-1.0 cm. The analgesic effect of PNB was significant, the mean pain score (2.8 ± 2.2) was significantly lower than that with topical anesthesia (P<0.0001). Patients during the PNB phase did not experience injection pain following CCLAD. The peripheral nerve block technique can greatly ease the pain that occurs during laser treatment, especially for patients with larger lesions. CCLAD will allow PNB to be broadly applied in laser treatments.

5 April 2022 in Journal of Cosmetic Dermatology
Verified
Journal Article
Closed access
ALAnqi Li
Anqi Li
RFRouyu Fang
Rouyu Fang
QSQiuning Sun
Qiuning Sun

1 October 2022 in JAMA Dermatology
Verified
Journal Article
Closed access
PDF file
ALAnqi Li
Anqi Li
QSQiuning Sun
Qiuning Sun
Yellow nail syndrome (YNS) is a rare disease characterized by a triad of yellow nails, pulmonary manifestations, and lymphedema. The pathogenesis of YNS is not clear, and the treatment options are limited, with obscure therapeutic effects. In this article, we describe a patient with YNS and palmar primary hyperhidrosis (PHH) treated with botulinum toxin A (BTX-A) for whom improvements from treatment lasted for 6 years without recurrence. A 23-year-old man with excessive sweating of the bilateral palms and 20 yellow nails presented to our institution’s dermatology department (Peking Union Medical College Hospital). The patient had excessive sweating without specific cause since age 4 years, and he had a 13-year history of chronic sinusitis. At age 18 years, all the fingernails and toenails of the patient progressively developed yellow to green discoloration, slow growth, thickening, cross-ridging, overcurvature, and onycholysis (Figure, A). Fungal infection was ruled out by repeated negative potassium hydroxide and fungal culture. Based on the symptoms and medical history, the patient was diagnosed with PHH and YNS. His PHH was treated by injecting BTX-A to improve his symptoms. Before injection, BTX-A (LAN; Hengli) was diluted with normal saline to a concentration of 2 U per 0.1 mL. Treatment with BTX-A was administered by intradermal injections at the dermal-subcutaneous junction with a depth of 2 to 3 mm, and a total dose of 50 U for each palm was injected into the dermis at a 30° to 45° entry angle. Injection volumes of 0.1 mL (2U) were uniformly distributed into 25 sites about 1 to 2 cm apart. After 5 days, a substantial alleviation of excessive sweating was observed. Interestingly, the fingernails grew normally 3 months after the treatment. In contrast, there was no substantial change in the toenails without BTX-A injection. All except the right thumb fingernail appeared completely normal 6 months after injection (Figure, B), and the patient underwent another treatment with BTX-A injection with the same protocol. All the fingernails grew without any noticeable issue after 12 months, and no recurrence of yellow fingernails was noted during the follow-up time of 6 years. Identify all potential conflicts of interest that might be relevant to your comment. Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. Err on the side of full disclosure. If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response. Not all submitted comments are published. Please see our commenting policy for details.

28 March 2023 in Dermatologic Surgery
Verified
Journal Article
Closed access
ALAnqi Li
Anqi Li
XLXinwen Lin
Xinwen Lin
XMXuming Mao
Xuming Mao
QSQiuning Sun
Qiuning Sun
BACKGROUND: Extracellular matrix (ECM), a material with tissue repair function, is applied to treat various wounds. However, the role of ECM in facilitating wound healing after facial laser treatment remains elusive. OBJECTIVE: To assess the efficacy and safety of ECM in promoting wound healing after picosecond laser therapy (PLT). MATERIALS AND METHODS: Eighteen female subjects with benign pigmentation disorders were randomly assigned to the ECM (n = 9) and control groups (n = 9). After PLT, the ECM and control groups were treated with ECM and facial moisturizer in the first 7 days, respectively. The severity of erythema and edema was assessed using photographs. The duration of erythema, edema, scab shedding, postinflammatory hyperpigmentation incidence (PIH), and adverse events was documented in detail. RESULTS: Compared with the control group, the ECM group had a shorter duration of erythema, edema, and scab shedding after PLT (p < .01). A significantly decreased severity of erythema (p < .05) and edema (p < .01) was found in the ECM group versus the control group, respectively. The PIH incidence in the ECM group was lower than in controls, albeit without statistical significance. No serious adverse events were observed during the follow-up. CONCLUSION: Extracellular matrix is an effective and safe dressing for promoting wound healing after PLT.